Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors


Oral ritlecitinib approved in US for alopecia areata

Written by | 3 Jul 2023

The FDA recently approved the Janus kinase (JAK) inhibitor ritlecitinib (Litfulo) for adults and adolescents with severe alopecia areata. It is, so far, the only treatment approved by the FDA… read more.

Long Covid symptoms include hair and libido loss

Written by | 30 Jul 2022

People who suffer long-term consequences of Covid-19 can experience a wide range of symptoms. As the precise nature and duration of Long Covid is still being untangled by… read more.

COVID vaccination linked to hair loss

Written by | 30 Mar 2022

A  report of nine cases of alopecia areata (AA) following SARS-CoV-2 vaccination appears to confirm suspicions that mRNA vaccines can trigger autoimmune responses that lead to hair loss…. read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.


You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.